-
Product Insights
Cognitive Impairment – Drugs In Development, 2023
Global Markets Direct’s, ‘Cognitive Impairment - Drugs In Development, 2023’, provides an overview of the Cognitive Impairment pipeline landscape. The report provides comprehensive information on the therapeutics under development for Cognitive Impairment, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Traumatic Brain Injury – Drugs In Development, 2023
Global Markets Direct’s, ‘Traumatic Brain Injury - Drugs In Development, 2023’, provides an overview of the Traumatic Brain Injury pipeline landscape. The report provides comprehensive information on the therapeutics under development for Traumatic Brain Injury, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Tshipi Borwa Mine
The Tshipi Borwa Mine is a manganese mine in South Africa. It is currently in operation. Empower your strategies with our Tshipi Borwa Mine report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AB-107 in Psoriasis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AB-107 in Psoriasis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.AB-107 in Psoriasis Drug Details:AB-107 is under development for the treatment of psoriasis. It...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – JNS-101 in Friedreich Ataxia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - JNS-101 in Friedreich Ataxia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.JNS-101 in Friedreich AtaxiaDrug Details:JNS-101 is under development for the treatment of Friedreich’s...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PHIN-214 in Portal Hypertension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PHIN-214 in Portal Hypertension report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.PHIN-214 in Portal HypertensionDrug Details:PHIN-214 is under development for the treatment of portal...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – JW-100 in Herpes Labialis (Oral Herpes)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - JW-100 in Herpes Labialis (Oral Herpes) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.JW-100 in Herpes Labialis (Oral Herpes) Drug Details:JW-100 (CaniDermRX) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GSK-4381562 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GSK-4381562 in Solid Tumor report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.GSK-4381562 in Solid Tumor Drug Details:GSK4381562 is under development for the treatment of...
-
Thematic Analysis
Batteries – Thematic Intelligence
Explore the following trends and insights from the ‘Batteries’ thematic report: Synopsis of the batteries theme and understand its progress over the past decade. Key trends impacting the growth of the theme over the next 12 to 24 months, namely, technology trends, macroeconomic trends, and regulatory trends. Multiple data sets, including patents and M&A trends, to set smart business goals. The report also provides a timeline highlighting milestones in the development of the batteries. Core segments of the value chain, including...